ReviewCancers2022

A 'Hybrid' Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy.

Hongshan Ji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.